Page last updated: 2024-10-22

albuterol and Renal Colic

albuterol has been researched along with Renal Colic in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Renal Colic: A severe intermittent and spasmodic pain in the lower back radiating to the groin, scrotum, and labia which is most commonly caused by a kidney stone (RENAL CALCULUS) passing through the URETER or by other urinary track blockage. It is often associated with nausea, vomiting, fever, restlessness, dull pain, frequent urination, and HEMATURIA.

Research Excerpts

ExcerptRelevanceReference
"Renal colic is the pain experienced by a patient when a renal calculus (kidney stone) causes partial or complete obstruction of part of the renal outflow tract."3.11Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC). ( Bedford, E; Chester, V; Fakis, A; Jackson, R; Johnson, G; Mason, S; Ratan, H; Sherman, R; Tabner, A, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Johnson, G1
Tabner, A1
Fakis, A1
Sherman, R1
Chester, V1
Bedford, E1
Jackson, R1
Ratan, H1
Mason, S1

Trials

1 trial available for albuterol and Renal Colic

ArticleYear
Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC).
    Trials, 2022, Apr-25, Volume: 23, Issue:1

    Topics: Albuterol; Analgesia; Analgesics; Clinical Trials, Phase II as Topic; Humans; Nausea; Pain; Prospect

2022